More News – Page 134
-
NewsOne Health surveillance tool proved vital in rapid response to rabies outbreak
Scientists have revealed that the use of an animal rescue system – Hawk Data Pro – proved to be a vital ‘One Health’ surveillance tool as part of a rapid response to a potentially deadly rabies outbreak in Pune city, India.
-
NewsMainstay malaria drug may be beginning to fail in the Horn of Africa
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria’s impact if partner drugs fail in the future.
-
NewsInfamous ‘eagle killer’ cyanobacterium produces not one, but two toxins
Two years ago, researchers established that a toxin from the cyanobacterium Aetokthonos hydrillicola is the cause of a mysterious disease among bald eagles in the USA - now they have described an elusive second toxin.
-
NewsFungal aroma can be used for behavioural pest control
Scientists exploring how blueberries infected with fungus Colletotrichum fioriniae emit odours which repel spotted-wing drosophila are able to trick the flies into perceiving healthy fruit as infected.
-
NewsResearchers combat Zika-associated foetal abnormalities using microRNA
Researchers have studied how the Zika virus persists in the placenta for long periods of time and how to mitigate it.
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsHERV-W virus acting as neuropathogen successfully confirmed
Scientists have described a direct functional connection between the release of an endogenous retrovirus and the worsening of neurodegenerative processes in multiple sclerosis.
-
NewsNew test for sepsis could save lives in emergency departments
Interdisciplinary research has found that a new blood test for sepsis could save lives and money.
-
NewsSRI spins off AI-powered drug discovery platform Synfini, Inc
SRI International has announced it is spinning off Synfini, a biosciences platform that accelerates the process by which pharmaceutical and other companies can design, synthesize, and bring to market molecules for drug development.
-
NewsMineral nanoparticles can help fungi break down organic pollutants in soils
Mineral nanoparticles could potentially act as nanozyme mimics, assisting fungi in breaking down organic pollutants in soils, a new study has found.
-
NewsTwo new species of oil-forming yeast discovered
A research group has discovered two new species of oil-forming yeast in the soil of Shiga Prefecture in Japan. Their study also examines the relationship between the prefecture’s diverse climate and microbial ecology.
-
NewsScientists uncover new pathway of diatom-mediated calcification
Researchers have found that the photosynthesis of a common diatom can induce substantial aragonite precipitation from artificial/natural seawater under significantly lower supersaturation levels required for the precipitation of inorganic CaCO3.
-
NewsScientists probe amoeba that thrives at 125°F
Biologists study the mechanisms that have allowed microbial eukaryotes to thrive in the extreme conditions of a geothermal lake.
-
NewsContagious omicron strain replicates early in infection
New research used engineered mice to compare SARS-COV-2 omicron subvariants and found one of them – BA.5 – was more virulent likely due to its ability to rapidly replicate early during infection.
-
NewsValneva announces new IXIARO® supply contract with the US government
Specialty vaccine company Valneva SE has announced the signing of a new $32 million contract with the United States Department of Defense for the supply of its Japanese encephalitis vaccine, IXIARO®.
-
NewsAntibiotics can help some bacteria survive for longer
Scientists have found a surprising effect of some antibiotics on certain bacteria – that the drugs can sometimes benefit bacteria, helping them live longer.
-
NewsResearchers pioneer safe chemotherapy methods for treating bacterial infections
Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow. A group of proven drugs used in cancer treatment for decades could possibly be the solution. A new class of antibiotics is now being developed by researchers at ...
-
NewsNew vaccine technology could protect from future viruses and variants
Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals.
-
NewsAntiviral drug linked to SARS-CoV-2 mutations
Researchers have uncovered a link between an antiviral drug for COVID-19 infections called molnupiravir and a pattern of mutations in the SARS-CoV-2 virus.
-
NewsResearchers reveal how microbes return after a wildfire
A study suggests that dispersal - through air or rain, for example - plays a major role in microbial succession after a destructive fire.
